THE EVALUATION OF ANTI-TUMOR PROPERTIES OF B. SUBTILIS IMV B-7724 LECTIN IN VIVO STUDIES

Authors

  • A.V. Chumak R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv, Ukraine
  • N.I. Fedosova R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv, Ukraine
  • N.L. Cheremshenko R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv, Ukraine
  • O.M. Karaman R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv, Ukraine
  • T.V. Symchych R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NAS of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.32471/oncology.2663-7928.t-24-1-2022-g.10306

Keywords:

antitumor activity, B. subtilis IMB B-7724 lectin, Ehrlich adenocarcinoma, Lewis lung carcinoma

Abstract

Aim: to investigate antitumor efficacy of lectin produced by B. subtilis IMV B-7724 on Ehrlich adenocarcinoma and Lewis lung carcinoma in vivo. Object and methods: the studies were performed on C57Bl/6J (n = 20) and Balb/c (n = 20) mice. In the investigation, the two experimental tumors were used: Ehrlich adenocarcinoma (EAC) and Lewis lung carcinoma (LLC). Starting from day 2 after the tumor cells transplantation, B. subtilis IMV B-7724 lectin was administered (s/c, 1 mg/kg of body weight, every other day, a total course consisted of 10 injections). The frequency of tumor development after the transplantation (%), the latent period of tumor appearance, the tumor volume (mm3), and the survival of the tumor-bearing animals were under evaluation. The statistical analysis of the results was performed according to the generally accepted methods of variation statistics. Results: The administration of bacterial lectin to mice bearing either EAC or LLC helped to slow the growth of experimental tumors and prolonged the survival time of tumor-bearing animals. More pronounced antitumor activity of the lectin was observed in mice bearing EAC. The index of tumor growth inhibition in this group of animals reached 53.2 ± 1.4%. In the mice bearing LLC, the administration of bacterial lectin showed a tendency to slow down the metastatization: the index of metastatization inhibition was 36.0 ± 4.5%. In the EAC-bearing mice, the course of 10-times lectin administration resulted in a statistically significant increase in survival time of 1.8 times comparing with the untreated control, p <0.05. When LLC tumor was used as an experimental model, the positive effect of B. subtilis IMV B-7724 lectin on the survival time of the tumor-bearing animals was expressed to a much lesser extent. The index of tumor growth inhibition reached only 18.2 ± 1.8%; the survival time increased by 33.3%. Conclusion: the antitumor efficacy of B. subtilis IMV B-7724 lectin was demonstrated in the animals bearing experimental tumors. Considering the standard indexes of tumor growth evaluation, the lectin application was more effective in non-metastatic solid Ehrlich adenocarcinoma.

References

Hopper JTS, Ambrose S, Grant OC, et al. The tetrameric plant lectin banlec neutralizes HIV through bidentate binding to specific viral glycans. Structure 2017; 25 (5): 773–82.e5. doi: 10.1016/j.str.2017.03.015

Asaduzzaman AKM, Hasan I, Chakrabortty A, et al. Moringa oleifera seed lectin inhibits Ehrlich ascites carcinoma cell growth by inducing apoptosis through the regulation of Bak and NF-κB gene expression. Int J BiolMacromol 2018; 107 (Pt B): 1936–44. doi: 10.1016/j.ijbiomac.2017.10.070

Mbae KM, Umesha S, Manukumar HM. The rapeutic pro­perties of lectins in herbal supplements. Phytochem Rev 2018; 17 (3): 627–43. doi:10.1007/s11101-018-9572-2

Singh RS, Walia AK. Microbial lectins and their prospective mitogenic potential. Crit Rev Microbiol 2013; 40 (4): 329–347. doi: 10.3109/1040841X.2012.733680

Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol 2019; 15 (6): 346–66. doi: 10.1038/s41581-019-0129-4

Pearce OMT. Cancer glycan epitopes: biosynthesis, structure and function. Glycobiology 2018; 28 (9): 670–96. doi: 10.1093/glycob/cwy023

Taniguchi N, Kizuka Y. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res 2015; 126: 11–51. doi: 10.1016/bs.acr.2014.11.001

Mazalovska M, Kouokam JC. Plant-derived lectins as potential cancer therapeutics and diagnostic tools. Biomed Res Int 2020; 1631394. doi:10.1155/2020/1631394

Gupta A. Emerging applications of lectins in cancer detection and biomedicine. Materials Today: Proceedings 2020; 31 (2): 651–61. doi:10.1016/j.matpr.2020.05.810

Ryva B, Zhang K, Asthana A, et al. Wheat germ agglutininasa potential therapeutic agentfor leukemia. Front Oncol 2019; 9: 100. doi: 10.3389/fonc.2019.00100

Shi Z, Li WW, Tang Y, Cheng LJ. A novel molecular model of plant lectin-induced programmed cell death in cancer. Biol Pharm Bull 2017; 40 (10): 1625–29. doi: 10.1248/bpb.b17-00363

Cavada BS, Silva MTL, Osterne VJS, et al. Canavalia bonariensis lectin: molecular bases of glycoconjugates interaction and antiglioma potential. Int J Biol Macromol 2018; 106: 369–78. doi: 10.1016/j.ijbiomac.2017.08.023

Fu LL, Zhou CC, Yao S, et al. Plant lectins: targeting programmed cell death pathways as antitumor agents. Int J Biochem Cell Biol 2011; 43: 1442–9. doi: 10.1016/j.biocel.2011.07.004

Marvibaigi M, Supriyanto E, Amini N, et al. Preclinical and clinical effects of mistletoe against breast cancer. Biomed Res Int 2014; 2014: 1–15. doi: 10.1155/2014/785479

Podgorskii VS, Kovalenko EA, Karpova IS, et al. Extracellular lectin from saprophytic strains of bacteria of the genus Bacillus. Prikladnaia biokhimiia i mikrobiologiia 2014; 50 (3): 256–63. (in Russian) https://doi.org/10.1134/S0003683814030120

Tanasienko OA, Rudyk MP, Pozur VV, Potebnya GP. Influence of bacterial lectins on some reactions of nonspecific immunity in sarcoma 37 transplanted mice. Exp oncol 2010; 32 (4): 254–7. https://exp-oncology.com.ua/wp/wp-content/uploads/magazine/880.pdf?upload=

Fedosova NI, Cheremshenko NL, Hetman KI, et al. Physicochemical and cytotoxicity properties of Bacillus subtilis ІМВВ-7724 extracellular lectin. Mikrobiol Z 2021; 83 (1): 39–48. https://doi.org/10.15407/microbiolj83.01.039

Chumak A, Shcherbina V, Fedosova N, Chekhun V. Polarization of macrophages of mice under the influence of lectin from Bacillus subtilis IMB B-7724. EUREKA: Life Sciences 2021; 3: 3–10. doi: 10.21303/2504-5695.2021.001878.

European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes ETS 123. Protection of Vertebrate Animals, 18.III.1986. 48. https://norecopa.no/media/2iydns5h/ets-123-original.pdf

Kozhemyakin UM, Filonenko MA, Saifetdinova GA. Scientific and practical recommendations for keeping laboratory animals and working with them. Kyiv: Avitsena; 2002; 156p (in Ukrainian).

Stefanov OV. Doklinichni doslidzhennya likarskykh zasobiv [Preclinical studies of drugs]. Kyiv: Avitsena; 2001 (in Ukrainian).

Dunham LJ, Stewart HL. A survey of transplantable and transmissible animal tumors. J Natl Cancer Inst 1953; 13 (5): 1299–377. https://pubmed.ncbi.nlm.nih.gov/13035452/

Chekhun VF, Didenko GV, Cheremshenko NL, et al. Strain of bacteria Bacillus subtilis ІMB В-7724 — producer of cytotoxic substances with antitumor activity (Pat.№131824 UA). Publ. 25.01.2019. Bul 2. (in Ukrainian).

Podgorsky VS. The method for the obtainmen of bacterial lectin, specific to sialic acids. (Pat. № 1791 UA). Publ. 23.01.1991. (in Ukrainian).

Sidenko AB, Vishnyakov VV, Isaev SM. Theory of statistics. М: MAX-Press, 2011. 343 p. (in Russian)

Zheng C, Terreni M, Sollogoub M, Zhang Y. Ganglioside GM3 and its role in cancer. Curr Med Chem 2019; 26 (16): 2933–47. doi: 10.2174/0929867325666180129100619

Magalhães A, Duarte HO, Reis CA. Aberrant glycosylation in cancer: a novel molecular mechanism controlling metastasis. Cancer Cell 2017; 31 (6): 733–5. doi: 10.1016/j.ccell.2017.05.012

Day CJ, Paton AW, Higgins MA, et al. Structure aided design of a Neu5Gc specific lectin. Sci Rep 2017; 7 (1): 1495. doi: 10.1038/s41598-017-01522-9

Dobie C, Skropeta D. Insights into the role of sialylation in cancer progression and metastasis. Br J Cancer 2021; 124 (1), 76–90. https://doi.org/10.1038/s41416-020-01126-7

Li C, Chen J, Lu B, et al. Molecular switch role of Akt in Polygonatum odoratum lectin-induced apoptosis and autophagy in human non-small cell lung cancer A549 cells. PLoS One 2014; 9 (7): e101526. doi: 10.1371/journal.pone.0101526

Fedosova NI, Karaman OM, Voeykova IM, et al. Compa­rison of the efficacy of different regimens of application of xenogeneic cancer vaccine on models of metastatic tumor growth. Oncology 2017; 19 (2): 145–50. (in Ukrainian).

Published

2026-01-13

How to Cite

Chumak , A., Fedosova , N., Cheremshenko , N., Karaman , O., & Symchych , T. (2026). THE EVALUATION OF ANTI-TUMOR PROPERTIES OF B. SUBTILIS IMV B-7724 LECTIN IN VIVO STUDIES. Oncology, 24(1), 31–36. https://doi.org/10.32471/oncology.2663-7928.t-24-1-2022-g.10306

Issue

Section

Original investigations